利培酮与舒必利对精神分裂症患者血脂代谢的影响(3)
 |
| 第1页 |
参见附件(4141KB，5页)。
[10] Ota M, Mori K, Nakashima AA, et al. mRNA expression levels of leptin-related substances can be modified in risperidone-injected rats [J]. Biogenic Amines,2005,19(3-4):299-308.
[11] Melksson KI, Hulting AL. Insulin and leptin levels in patients with schizophrenia or related psychoses-a comparison between different antipsychotic agents [J]. Psychopharmacology,2001,154(2):205-212.
[12] Hasnain M, Fredrickson S, Vieweg W, et al. Metabolic syndrome associated with schizophrenia and atypical antipsychotics[J]. Curr Diab Rep,2010,10(3):209-216.
[13] Hung GCL, Kuo CJ, Huang MC, et al. Sex differences in the association of weight gain and risperidone efficacy among schizophrenic patients [J]. Progress in Neuro-Psychopharmacology & Biological Psychiatry,2010,34(8):1523-1524.
[14] Melkersson KI, Hulting AL, Rane AJ. Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses [J]. Brit J Clin Pharmaco,2001,51(4):317-324.
[15] Baptista T, de Baptista E, Nmkny K, et al. Comparative effects of the antipsychotics sulpiride or risperidone in rats: bodyweight, food intake, body composition, hormones and glucose tolerance[J]. Brain Res,2002,957(1):144-151.
[16] Baptista T, de Baptista EA, Lalonde J, et al. Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection [J]. Prog Neuro Psychoph,2004,28(8):1305-1311.
(收稿日期：2011-03-29)
[基金项目] 国家自然科学基金(81000581)；上海市科学技术委员会科研计划项目(10ZR1425700)。
您现在查看是摘要介绍页，详见PDF附件(4141KB，5页)。